Ultrinia Overview
- Status
-
Private
- Latest Deal Type
-
2ndary - Private
Ultrinia General Information
Description
Developer of biomaterials and cell culture scaffolds designed to support biomedical research and drug development. The company develops nanofiber-based cell culture scaffolds for tissue engineering, stem cell research, cancer research, toxicology testing, and pharmacological studies, enabling research institutions, biotechnology companies, pharmaceutical developers, and laboratories to conduct in vitro experiments and cellular analyses.
Contact Information
Website
www.ultrinia.comCorporate Office
- Tallinn University of Technology
- Tallinn
- Estonia
Corporate Office
- Tallinn University of Technology
- Tallinn
- Estonia
Ultrinia Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Secondary Transaction - Private | 01-Jan-2026 | Completed | Generating Revenue | |||
| 2. Accelerator/Incubator | Completed | Generating Revenue | ||||
| 1. Seed Round | 03-Sep-2014 | $66.4K | $66.4K | Completed | Generating Revenue |
Ultrinia FAQs
-
Where is Ultrinia headquartered?
Ultrinia is headquartered in Tallinn, Estonia.
-
What industry is Ultrinia in?
Ultrinia’s primary industry is Biotechnology.
-
Is Ultrinia a private or public company?
Ultrinia is a Private company.
-
What is Ultrinia’s current revenue?
The current revenue for Ultrinia is .
-
How much funding has Ultrinia raised over time?
Ultrinia has raised $66.4K.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process